Quick Answer
TREDEGAR CORP reported Total Revenue of $961.33 million for fiscal year 2017.
TREDEGAR CORP — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | — | — | — | — | — | — |
| Net Income | $33.48M +151.8% |
-$64.56M +39.0% |
-$105.91M -472.2% |
$28.45M -50.8% |
$57.83M +176.6% |
-$75.44M -256.3% |
| Diluted EPS | $0.96 +151.1% |
-$1.88 +39.4% |
-$3.10 -469.0% |
$0.84 -51.2% |
$1.72 +176.1% |
-$2.26 -255.9% |
| Total Assets | $371.37M +4.2% |
$356.36M -20.2% |
$446.46M -17.6% |
$542.09M +3.5% |
$523.58M +1.7% |
$514.87M -27.8% |
| Cash and Equivalents | $6.73M -4.7% |
$7.06M -26.9% |
$9.66M -49.8% |
$19.23M -37.0% |
$30.52M +157.6% |
$11.85M -62.3% |
| Long-Term Debt | $34.55M -43.0% |
$60.60M | $0.00 -100.0% |
$137.00M +87.7% |
$73.00M -45.5% |
$134.00M +219.0% |
| Stockholders Equity | $216.55M +19.7% |
$180.97M +16.3% |
$155.65M -22.9% |
$201.76M +9.2% |
$184.72M +69.4% |
$109.06M -71.1% |
| R&D Expense | $702.0K -1.3% |
$711.0K -75.4% |
$2.89M -45.6% |
$5.32M -16.1% |
$6.35M -24.4% |
$8.40M +6.4% |
| Shares Outstanding | 34.74M +0.2% |
34.66M +0.7% |
34.41M +1.2% |
34.00M +0.8% |
33.74M +0.8% |
33.46M +0.3% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | June 30, 2018 | $263.76M | +6.6% | +2.0% |
| Net Income | September 30, 2025 | $7.07M | +279.3% | +308.7% |
| Diluted EPS | September 30, 2025 | $0.20 | +281.8% | +300.0% |
| Total Assets | September 30, 2025 | $378.81M | -14.4% | +1.9% |
| Cash and Equivalents | September 30, 2025 | $13.29M | +387.9% | +35.7% |
| Long-Term Debt | September 30, 2025 | $49.50M | +147.5% | -20.2% |
| Stockholders Equity | September 30, 2025 | $202.19M | +27.6% | +4.2% |
| R&D Expense | March 31, 2025 | $165.0K | +9.3% | -65.3% |
| Shares Outstanding | September 30, 2025 | 34.89M | +1.1% | +0.0% |
- TREDEGAR CORP reported Total Revenue of $961.33 million for fiscal year 2017.
- TREDEGAR CORP showed an increase of +16.1% in Total Revenue compared to the prior fiscal year.
- TREDEGAR CORP reported Net Income of $33.48 million for fiscal year 2025.
- TREDEGAR CORP showed an increase of +151.8% in Net Income compared to the prior fiscal year.
- TREDEGAR CORP reported Diluted EPS of $0.96 per share for fiscal year 2025.
- TREDEGAR CORP showed an increase of +151.1% in Diluted EPS compared to the prior fiscal year.
- TREDEGAR CORP reported Total Assets of $371.37 million for fiscal year 2025.
- TREDEGAR CORP showed an increase of +4.2% in Total Assets compared to the prior fiscal year.
- TREDEGAR CORP reported Cash and Equivalents of $6.73 million for fiscal year 2025.
- TREDEGAR CORP showed a decrease of -4.7% in Cash and Equivalents compared to the prior fiscal year.
- TREDEGAR CORP reported Long-Term Debt of $34.55 million for fiscal year 2025.
- TREDEGAR CORP showed a decrease of -43.0% in Long-Term Debt compared to the prior fiscal year.
- TREDEGAR CORP reported Stockholders Equity of $216.55 million for fiscal year 2025.
- TREDEGAR CORP showed an increase of +19.7% in Stockholders Equity compared to the prior fiscal year.
- TREDEGAR CORP reported R&D Expense of $702.0 thousand for fiscal year 2025.
- TREDEGAR CORP showed a decrease of -1.3% in R&D Expense compared to the prior fiscal year.
- TREDEGAR CORP reported Shares Outstanding of 34.74 million shares for fiscal year 2025.
- TREDEGAR CORP showed an increase of +0.2% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: